Revive Therapeutics Updates, on Phase III Clinical Trial!

Michael Frank, CEO of the Company commented, "We are now in the final stages in our Phase 3 study.."

Revive Therapeutics (RVVTF) Provides Update of Psilocybin Pharmaceutical Programs

IRB approval to initiate Phase 2 study for methamphetamine abuse disordersAdvancing psilocybin oral thin film, microneedle patch and biosynthesis programs
Fuqua Professor David Ridley

Everything You Need to Know About FDA’s Priority Review Vouchers Worth $100’s of Millions.

Never Heard of These 'PRV's' but What a Potential Bonanza for the Recipients. They're transferable - as in they can be...

Adding Immix Biopharma (IMMX) to 2022 Biotech 12 Pack List.

Added to 12 Biotech Stocks we Expect to Double List. The Original Biotech 6-Pack from 2020, is Growing to...

Ehave’s Mobile Ketamine Clinic, Rolling into Town.

Longer term, Ehave's (EHVVF) performance has been a quite a disappointment. Investors grew impatient for the launch...
VYRE Network

Report: VYRE Network (CAPV).

Update Report: Our First Internet Play in Ages, and It’s a Doozy. Reporting from the Great City...

The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...

The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21. Revive Therapeutics (RVTTF), RedHill BioPharma...

Reuniting With the Affable Mr. Greg Halpern, 19 Years Later…

A Potential Christmas Present Arrives in our lap Early, From the Inventor of Crowdfunding and Winner of Incubator of The Year in...
CPRE Networks

Adding VYRE Network (CAPV) to the Watch List.

Look What We Found. Our First Internet Play in Ages, And It's a Doozy. We would categorize this...

Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)

Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...